|
J. Biol. Chem., Vol. 261, Issue 25, 11667-11673, Sep, 1986
Expression of human malaria parasite purine nucleoside phosphorylase in host enzyme-deficient erythrocyte culture. Enzyme characterization and identification of novel inhibitors
PE Daddona, WP Wiesmann, W Milhouse, JW Chern, LB Townsend, MS Hershfield and HK Webster
The intraerythrocytic human malaria parasite, Plasmodium falciparum,
requires a source of hypoxanthine for nucleic acid synthesis and energy
metabolism. Adenosine has been implicated as a major source for
intraerythrocytic hypoxanthine production via deamination and
phosphorolysis, utilizing adenosine deaminase and purine nucleoside
phosphorylase, respectively. To study the expression and characteristics of
human malaria purine nucleoside phosphorylase, P. falciparum was
successfully cultured in purine nucleoside phosphorylase- deficient human
erythrocytes to an 8% parasitemia level. Purine nucleoside phosphorylase
activity was undetectable in the uninfected enzyme-deficient host red cells
but after parasite infection rose to 1.5% of normal erythrocyte levels. The
parasite purine nucleoside phosphorylase was not cross-reactive with
antibody against human enzyme, exhibited a calculated native molecular
weight of 147,000, and showed a single major electrophoretic form of pI 5.4
and substrate specificity for inosine, guanosine and deoxyguanosine but not
xanthosine or adenosine. The Km values for substrates, inosine and
guanosine, were 4-fold lower than that for the human erythrocyte enzyme. In
these studies we have identified two novel potent inhibitors of both human
erythrocyte and parasite purine nucleoside phosphorylase,
8-amino-5'-deoxy-5'-chloroguanosine and 8-amino-9-benzylguanine. These
enzyme inhibitors may have some antimalarial potential by limiting
hypoxanthine production in the parasite-infected erythrocyte.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. C. Madrid, L.-M. Ting, K. L. Waller, V. L. Schramm, and K. Kim
Plasmodium falciparum Purine Nucleoside Phosphorylase Is Critical for Viability of Malaria Parasites
J. Biol. Chem.,
December 19, 2008;
283(51):
35899 - 35907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Downie, K. Kirk, and C. B. Mamoun
Purine Salvage Pathways in the Intraerythrocytic Malaria Parasite Plasmodium falciparum
Eukaryot. Cell,
August 1, 2008;
7(8):
1231 - 1237.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-M. Ting, W. Shi, A. Lewandowicz, V. Singh, A. Mwakingwe, M. R. Birck, E. A. T. Ringia, G. Bench, D. C. Madrid, P. C. Tyler, et al.
Targeting a Novel Plasmodium falciparum Purine Recycling Pathway with Specific Immucillins
J. Biol. Chem.,
March 11, 2005;
280(10):
9547 - 9554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Kicska, P. C. Tyler, G. B. Evans, R. H. Furneaux, K. Kim, and V. L. Schramm
Transition State Analogue Inhibitors of Purine Nucleoside Phosphorylase from Plasmodium falciparum
J. Biol. Chem.,
January 25, 2002;
277(5):
3219 - 3225.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|